Sort
16,179 grants matching “malaria”
DCTD Biopharmaceutical Development
$5,333,006David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA
VTEU Supplement
$5,179,983Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2021 · AI
Malaria Vaccine Production and Support Services
$5,173,244Kathleen Kootz · Science Applications International Corp · N01 · FY2010 · AI
Biodefense and Emerging Infectious Disease Vaccine Studies
$5,127,139Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
CoVPN - COVID Countermeasures
$5,088,428Ann R Falsey · University Of Rochester · UM1 · FY2020 · AI
PRECLINICAL DEVELOPMENT OF MMV609, A SECOND-GENERATION ATP4I, FOR MALARIA
$5,072,634Regents Of The University Of Minnesota · · FY2025 · Defense Health Agency
Infectious Disease Genomics: Pathogen Evolution, Emergence, and Host Interaction
$5,063,540Bruce W. Birren · Broad Institute, Inc. · U19 · FY2017 · AI
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA
$5,020,301Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Development of Pre-Erythrocytic Malaria Vaccines
$5,012,423Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
IID Vaccine Evaluation and Development
$5,000,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA
Broad Institute Comprehensive Screening Center
$5,000,000Stuart L Schreiber · Broad Institute, Inc. · U54 · FY2012 · HG
Biodefense and Emerging Infectious Disease Vaccine Studies
$4,962,764Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Structural Genomics of Pathogenic Protozoa
$4,868,309University Of Washington · P50 · FY2003 · GM
DEVELOPMENT OF SAFER DRUGS FOR MALARIA AND LEISHMANIASIM IN US TROOPS, CIVILIAN PERSONNEL AND TRAVELERS
$4,801,212The University Of Mississippi · · FY2008 · Department of the Army
Immunization against Multidrug-resistant Pathogens: Activating T Cell Immunity (IMPACT-CETR)
$4,776,780Richard Malley · Boston Children'S Hospital · U19 · FY2025 · AI
MALARIA VACCINE PRODUCTION AND SUPPORT SERVICES
$4,730,568Kathleen Kootz · Science Applications International Corp · N01 · FY2012 · AI
Vaccine and Treatment Evaluation Units
$4,699,209Nadine Georges Rouphael · Emory University · UM1 · FY2022 · AI
Biodefense/Emerging Infection Vaccine Studies
$4,674,742Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
CoVPN 3004 - A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine - LC3
$4,637,125Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit
$4,613,138Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2021 · AI
Data Coordinating Center for the Sickle Cell Disease Clinical Research Network
$4,527,221Sonja M McKinlay · New England Research Institutes, Inc. · U10 · FY2008 · HL
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans
$4,499,507Anna Karolina Palucka · Baylor Research Institute · U19 · FY2010 · AI
Structural Genomics of Pathogenic Protozoa
$4,435,865University Of Washington · P50 · FY2001 · GM
Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention
$4,434,672Marc Michael Baum · Oak Crest Institute Of Science · U19 · FY2016 · AI
Advancing Genomic Technologies to Combat Infectious Disease: Mapping Dynamics within Single Cells, Individual Hosts, and Global Populations
$4,400,000Bruce W. Birren · Broad Institute, Inc. · U19 · FY2019 · AI